PRKG1 and neuropathy: We’ve shown previously that increasing proteasome function in S63del by pharmacologically raising cGMP and stimulating phosphorylation of 26S proteasomes by PKG reduces the biochemical indicators of the proteotoxicity seen in S63del neuropathy (VerPlank et al, 2022).